Rallybio Corp Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Rallybio Corp Stock Summary

Rallybio Corp competes with Century Therapeutics, Edgewise Therapeutics, C4 Therapeutics, Mineralys Therapeutics,, and Cullinan Oncology. Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut. Rallybio Corporaton operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.

Rallybio Corp Key Financial Ratios

Rallybio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Rallybio Corp's current stock value. Our valuation model uses many indicators to compare Rallybio Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rallybio Corp competition to find correlations between indicators driving Rallybio Corp's intrinsic value. More Info.Rallybio Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Rallybio Corp's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rallybio Corp's earnings, one of the primary drivers of an investment's value.

Rallybio Corp Systematic Risk

Today, most investors in Rallybio Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rallybio Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Rallybio Corp growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Rallybio Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rallybio Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rallybio Corp based on widely used predictive technical indicators. In general, we focus on analyzing Rallybio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rallybio Corp's daily price indicators and compare them against related drivers.

When running Rallybio Corp's price analysis, check to measure Rallybio Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rallybio Corp is operating at the current time. Most of Rallybio Corp's value examination focuses on studying past and present price action to predict the probability of Rallybio Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rallybio Corp's price. Additionally, you may evaluate how the addition of Rallybio Corp to your portfolios can decrease your overall portfolio volatility.